DANYELZA is a prescription medicine used in combination with a medicine called granulocyte-macrophage colony-stimulating factor (GM-CSF) to treat children 1-year of age and older and adults with high-risk neuroblastoma in the bone or bone marrow that:
It is not known if DANYELZA is safe and effective in children younger than 1 year of age.
DANYELZA is a prescription medicine used in combination with a medicine called granulocyte-macrophage colony-stimulating factor (GM-CSF) to treat children 1-year of age and older and adults with high-risk neuroblastoma in the bone or bone marrow that:
It is not known if DANYELZA is safe and effective in children younger than 1 year of age.
DANYELZA®, Y-mAbs®, Y-mAbs Connect®, and the logos for DANYELZA® and Y-mAbs Connect® are registered trademarks of Y-mAbs Therapeutics, Inc. The logo for Y-mAbs Therapeutics, Inc. is a trademark for Y-mAbs Therapeutics, Inc.
© 2024 Y-mAbs Therapeutics, Inc. All rights reserved. August 2024 NAX-000346_v4
Yes, I am a US Healthcare Professional and would like to continue.
If you are not a US Healthcare Professional, please click RETURN to be redirected to the patient/caregiver website.